Acid phosphatase activity of liver homogenates and its relation to drug activity in rats infected with Mycobacterium lepraemurium.
D000135:Acid Phosphatase / Q000032:analysis*; D000273:Adipose Tissue / Q000473:pathology; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D008099:Liver / Q000201:enzymology* / Q000473:pathology; D008168:Lung / Q000473:pathology; D009852:Omentum / Q000473:pathology; D009929:Organ Size; D051381:Rats; D013154:Spleen / Q000473:pathology; D013450:Sulfones / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use
D000890:Anti-Infective Agents; D013450:Sulfones; D013882:Thiosemicarbazones; D003622:Dapsone; D000135:Acid Phosphatase; D005000:Ethionamide; D007538:Isoniazid